Pfizer CEO Touts Trump Drug-Price Deal Amid Vaccine Doubts

Pfizer Inc. Chief Executive Officer Albert Bourla said that vaccines are harder to get approved right now as Health Secretary Robert F. Kennedy Jr. looks to overhaul the country’s immunization policies.

“It’s not harder to get drug approvals right now, it’s harder to get vaccine approvals,” Bourla said Wednesday during a wide-ranging conversation with CNBC that waded into his company’s US investments, deal with the Trump administration and the country’s current regulatory environment.